BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on Augus... ( LYNBROOK N.Y. Aug. 4 /- B...)

HOME >> BIOLOGY >> TECHNOLOGY

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009

Date:8/4/2009

LYNBROOK, N.Y., Aug. 4 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, announced today that the Company will host a conference call and live audio webcast at 4:30 p.m. ET on Wednesday, August 12, 2009 to discuss its second quarter 2009 financial results and corporate highlights.

To participate in the call, please dial 800-860-2442 (domestic) or 412-858-4600 (international). The live webcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com, or you may use the link: http://www.videonewswire.com/event.asp?id=61125.

A replay of the call will be available one hour after the conference ends on August 12, 2009 until 9:00 a.m. ET on August 20, 2009. To access the replay, please dial 877-344-7529 (domestic) or 412-317-0088 (international) and reference the access code 432828. The archived webcast will be available for 90 days in the Investor Relations section of the BioSpecifics' website at http://www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for three clinical indications: Dupuytren's disease; Peyronie's disease; and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium Pharmaceuticals, Inc. has announced the accepta
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/4/2009)...if., Dec. 4 BlueFire Eth...pany focused on changing the world,s transportatio...from non-food cellulosic wastes, has been ranked n...Hottest Companies in Bioenergy;" the company,s sec... voters rank BlueFire Ethanol among the top 20 bio...

(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...

(Date:12/3/2009)...alif., Dec. 3 Peregrine ...nced that it will release its financial results fo...er 10, 2009 at 7:00 a.m. EST and will host a confe...1:30 a.m. EST on the same day. ,, Peregrine,s s...r the second quarter ended October 31, 2009 and wi...

(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...

Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4 Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2 Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2 Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3

[0] BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year [0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe [0] Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results [0] Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India

...5 million in 2008 on target; Potential label ...SEATTLE, Aug. 18 Cell Therapeutics, Inc.,(CTI) (N...r the quarter,ended June 30, 2008. Total revenues ...000 for the second quarter of 2007 due primarily t...mmercial radiopharmaceutical that,CTI acquired in ...

... 15 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB , ...Deficiency Letter from The Nasdaq Stock Market,("N...y with the audit,committee composition requirement...ires XTL to maintain an audit committee comprised ... Israeli domiciled company, is required by the Isr...

...ing Record Profitability, HARBIN, China, Aug. 15 ...tus Biotech Inc. (the "Company") (OTC Bulletin Boa...er, manufacturer and marketer of a,variety of cact...ay record,second quarter results for the period en... $5.0 million, a 34.9% increase compared to $3.7 m...

Other Biology Technology:Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 2 Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 3 Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 4 Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 5 Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 6 Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 7 XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 2 XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 3 China Kangtai Cactus Biotech Announces Record Second Quarter Results 2 China Kangtai Cactus Biotech Announces Record Second Quarter Results 3

Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition China Kangtai Cactus Biotech Announces Record Second Quarter Results

(Date:12/2/2009)...ke their first cigarette within minutes after waki...oduct of nicotine when processed by the body, than... of cigarettes smoked. , "Since cotinine leve...results suggest that smokers who smoke immediately...ancer," said researcher Joshua E. Muscat, Ph.D., M...

(Date:12/2/2009)...condhand smoke for a prolonged period of time and ...ancer, even in women who never smoked cigarettes t...to side-stream smoke could increase risk of breast...nolds, Ph.D., senior research scientist at the Nor..."While no single epidemiologic study can answer th...

(Date:12/2/2009)...moky Mountain forest,s woodland herb population ha... understories recover from logging, according to P...ng in portions of the forest nearly 80 years ago, ...ry forest floor was similar to that of undisturbed...sor of forestry and natural resources, said that c...

Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2 Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2 Study finds logging effects vary based on a forest's history, climate 2 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6 Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7 NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 1 NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 2 NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 3 Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 1 Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 2 Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 3 Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 4

[1] Increased nicotine levels detected in those who light-up earlier [0] Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life [0] Study finds logging effects vary based on a forest's history, climate

... This release is available in French . , Cana...ed a DNA sequence that controls the variability of...ally significant discovery because high blood gluc...ndications of heart disease and higher mortality r...nline version of the journal Science. , The rese...

... The May 2008 issue of the Journal of the American...ch studies you may find of interest. Below is a su...formation or to receive a copy of a Journal articl...Following MyPyramid Advice, Prefer Foods High in F...he most nutrient-dense forms of the basic food gro...

... COLLEGE STATION Male seahorses are natures real-...level: Pregnancy. , Although it is common for ma...pregnancy is a complex process unique to the fish ...orses and sea dragons. Texas A&M University evolut...s in his lab are studying the effects of male preg...

Other Biology News:Genetic breakthrough explains dangerously high blood glucose levels 2 Genetic breakthrough explains dangerously high blood glucose levels 3 Highlights from the May 2008 Journal of the American Dietetic Association 2 Highlights from the May 2008 Journal of the American Dietetic Association 3 Male seahorses are nature's Mr. Mom, Texas A&M researchers say 2 Male seahorses are nature's Mr. Mom, Texas A&M researchers say 3 Male seahorses are nature's Mr. Mom, Texas A&M researchers say 4

Genetic breakthrough explains dangerously high blood glucose levels Highlights from the May 2008 Journal of the American Dietetic Association Male seahorses are nature's Mr. Mom, Texas A&M researchers say

EcoR I/Hind III End Modification Kit from Novagen

Silencer CellReady siRNA Transfection Optimization Kit from Ambion

SUPERaseIn from Ambion

...ly and negatively supercoiled DNA in presence of E...percoiling on transcription in vitro , Studying c...e degree of supercoiling of naturally occurring DN...th by only one base-pair , Increasing restriction...

Biology Products:

EcoR I/Hind III End Modification Kit from Novagen Silencer CellReady siRNA Transfection Optimization Kit from Ambion SUPERaseIn from Ambion Topoisomerase I (Vaccinia) from Molecular Cloning Laboratories (MCLAB)

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on Augus...( LYNBROOK N.Y. Aug. 4 /- B...)